
Strides Pharma hits 52-week high as CDMO arm secures ₹801 cr in pre-listing round
Strides Pharma Science announced that its associate, OneSource Specialty Pharma, has raised ₹801 crore from domestic and foreign institutional investors in a pre-listing round.








